Register to chat with like-minded investors on our interactive forums.

Get Started

ABUS Arbutus Biopharma Corporation

4.05

-0.09 (-2.17%)

Sep 21 2024 - Closed

Delayed by 15 minutes

Arbutus receives regulatory approval to start early-stage HBV trial

To read the full story on Seeking Alpha, click here.

Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Arbutus Biopharma Charts.

Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Arbutus Biopharma Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Arbutus Biopharma Corporation News

More Arbutus Biopharma Corporation News Articles

Lightwave Logic

Rennova Health (CE)

Voip Pal Com (QB)

Bioelectronics (PK)

Asia Broadband (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Sincerity Applied Materi... (PK)

Net Savings Link (PK)

Delayed Upgrade Clock